Copaxone
Generic Name:
Glatiramer
Brand Names:
Copaxone
Copaxone Description:
Copaxone is an injectable medication prescribed to reduce relapse symptoms in patients diagnosed with relapse-remitting multiple sclerosis (RMMS). Copaxone is an immunomodulator that works by preventing the body from damaging its nerve cells (myelin), extending the time between relapse.
Copaxone Side Effects:
The following side effects have been associated with Copaxone:
- Injection site reactions
- Flushing
- Rash
- Shortness of breath
- Chest pain
For more information, see our Copaxone side effects page.
Copaxone Uses:
Copaxone may be prescribed to extend the time between relapse symptoms in patients with RMMS. Copaxone changes the way the immune system reacts to multiple sclerosis by preventing harmful cells from developing while stimulating the production of healthy cells.
The injectable medicine allows the newly-developed healthy cells to enter the central nervous system and reduce the damage caused by RMMS.
Copaxone Interactions:
Patients should speak with their doctor about the use of any medications, vitamins or supplements before taking Copaxone.
Before beginning treatment with Copaxone, patients should consult their doctor if they are taking any medications similar to Copaxone.
Patients with a history or current diagnosis of kidney problems or infection should consult their doctor before treatment with Copaxone.
Copaxone Dosage Information:
Typical Dosage Recommendations
Copaxone dosages may vary among patients and conditions. Patients should take Copaxone exactly as prescribed by their doctor.
Copaxone is distributed in 20 ml prefilled dosing pens intended for once a day use in patients with RMMS.
Patients will receive their first dose of Copaxone at their doctor’s office. The remaining doses may be done by the patient, a friend, or relative.
Patients may inject their Copaxone dose into their arms, thighs, hips, or lower abdomen. However, patients should keep a rotating log of each injection site used to avoid negative skin side effects.
Allow your Copaxone dose to become room temperature by letting it sit for 20 minutes after removing it from the blister pack.
Wash your hands before administering Copaxone. Do not touch your hair or skin afterward. Wipe the injection area with alcohol before using your Copaxone dosing pen. Place a dry cotton ball over the injection site after administering Copaxone.
Do not use a prefilled Copaxone syringe more than once. Copaxone prefilled syringes should be disposed of in a hard, plastic container after each dose.
Missing a Dose of Copaxone
If you miss a dose of Copaxone, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and return to your normal dosing schedule. Do not double a dose to make up for your missed dose.
Copaxone Overdose
Patients who overdose on Copaxone may collapse or stop breathing. Call your doctor immediately if you believe you have overdosed on Copaxone.
Copaxone FDA Approval:
December 20, 1996
Copaxone Recall/Black Box Warning Information:
There are no recalls or Black Box warnings for Copaxone.
Other Warnings
Reactions may occur immediately after or several months into using Copaxone. While the reaction may be temporary and subside quickly, patients may experience flushing, chest pain, palpitations, anxiety, trouble breathing, throat closing, and hives. It is important for patients to notify their doctor of this reaction and seek immediate emergency medical attention if these symptoms are severe or do not go away.
Copaxone is designed to suppress the immune system. Patients may be at risk for developing certain infections or at greater risk for developing cancer.
Sources:
-
July 30, 2010, 2:23 pm
-
July 30, 2010, 2:13 pm
-
July 29, 2010, 12:33 pm
-
July 28, 2010, 3:58 pm
